National Mutual Insurance Federation of Agricultural Cooperatives Has $2,896,000 Stake in Thermo Fisher Scientific Inc (TMO)

National Mutual Insurance Federation of Agricultural Cooperatives held its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,600 shares of the medical research company’s stock at the close of the 2nd quarter. Thermo Fisher Scientific accounts for about 0.1% of National Mutual Insurance Federation of Agricultural Cooperatives’ portfolio, making the stock its 29th largest holding. National Mutual Insurance Federation of Agricultural Cooperatives’ holdings in Thermo Fisher Scientific were worth $2,896,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also bought and sold shares of TMO. Waldron LP boosted its holdings in Thermo Fisher Scientific by 48.1% in the first quarter. Waldron LP now owns 4,455 shares of the medical research company’s stock valued at $661,000 after purchasing an additional 1,447 shares during the last quarter. Empire Life Investments Inc. boosted its holdings in Thermo Fisher Scientific by 132.0% in the first quarter. Empire Life Investments Inc. now owns 52,504 shares of the medical research company’s stock valued at $7,861,000 after purchasing an additional 29,875 shares during the last quarter. Trust Co. of Vermont boosted its holdings in Thermo Fisher Scientific by 0.7% in the first quarter. Trust Co. of Vermont now owns 35,551 shares of the medical research company’s stock valued at $5,460,000 after purchasing an additional 249 shares during the last quarter. Xact Kapitalforvaltning AB boosted its holdings in Thermo Fisher Scientific by 2.2% in the first quarter. Xact Kapitalforvaltning AB now owns 78,898 shares of the medical research company’s stock valued at $12,119,000 after purchasing an additional 1,671 shares during the last quarter. Finally, Handelsbanken Fonder AB boosted its holdings in Thermo Fisher Scientific by 5.2% in the first quarter. Handelsbanken Fonder AB now owns 100,965 shares of the medical research company’s stock valued at $15,508,000 after purchasing an additional 5,000 shares during the last quarter. 83.36% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This news story was first published by Markets Daily and is the property of of Markets Daily. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.themarketsdaily.com/2017/10/11/national-mutual-insurance-federation-of-agricultural-cooperatives-has-2896000-stake-in-thermo-fisher-scientific-inc-tmo.html.

TMO has been the topic of several recent research reports. Cowen and Company reaffirmed an “outperform” rating and issued a $220.00 price target (up from $200.00) on shares of Thermo Fisher Scientific in a report on Sunday, September 10th. Goldman Sachs Group, Inc. (The) began coverage on shares of Thermo Fisher Scientific in a research note on Tuesday, September 26th. They set a “buy” rating and a $225.00 target price on the stock. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Tuesday, September 12th. Leerink Swann increased their target price on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a research note on Monday. Finally, Citigroup Inc. reissued a “buy” rating and set a $201.00 target price (up from $182.00) on shares of Thermo Fisher Scientific in a research note on Monday, July 10th. One investment analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $203.64.

Shares of Thermo Fisher Scientific Inc (TMO) opened at 192.64 on Wednesday. The stock has a market capitalization of $75.15 billion, a price-to-earnings ratio of 33.56 and a beta of 1.05. The stock’s 50 day moving average is $187.80 and its 200 day moving average is $174.71. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.27 by $0.03. The business had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The business’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.03 earnings per share. On average, equities analysts forecast that Thermo Fisher Scientific Inc will post $9.35 EPS for the current year.

In related news, VP Peter E. Hornstra sold 3,894 shares of the business’s stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $185.18, for a total transaction of $721,090.92. Following the sale, the vice president now owns 19,751 shares of the company’s stock, valued at $3,657,490.18. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Gregory J. Herrema sold 30,000 shares of the business’s stock in a transaction dated Wednesday, August 2nd. The stock was sold at an average price of $176.02, for a total transaction of $5,280,600.00. Following the sale, the senior vice president now directly owns 67,016 shares in the company, valued at approximately $11,796,156.32. The disclosure for this sale can be found here. In the last three months, insiders have sold 52,738 shares of company stock worth $9,302,112. 0.49% of the stock is owned by insiders.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply